Ann: Key Board Appointment, page-16

I'm actually a little irritated with these targets. My buy decision was largely based on their investor presentation which clearly nominated completion of a scoping study and commencement of feasibility studies in the next 6 months (presentation was in may). October 22 is a large departure from the milestone dates indicated.

can anyone explain further why there is optimism for these targets and where it indicates that scoping results by Aug? To me the target is quite explicit in that it is a goal to be completed by October 22